Lisa Vermunt

University of Amsterdam

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Neurology

100%

Neuropsychology

100%

Neurodegenerative Disease

100%

Cerebrospinal Fluid

70%

Neuropathology

70%

Proteostasis

60%

Neuroprotection

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Article Link

Year:

2025

Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia

Article Link

Year:

2025

Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia

Article Link

Year:

2024

The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases

Article Link

Year:

2024

Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges

Article Link

Year:

2024

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

Article Link

Year:

2024

Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer’s disease

Article Link

Year:

2024

Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias

Article Link

Year:

2023

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning

Article Link

Year:

2023

Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology

Article Link

Year:

2023

CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease

Article Link

Year:

2023

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia

Article Link

Year:

2023

Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases

Article Link

Year:

2023

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

Article Link

Year:

2023

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

Article Link

Year:

2022

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition

Article Link

Year:

2022

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface

Article Link

Year:

2022

Neurofilament light increases over time in severe COVID-19 and is associated with delirium

Article Link

Year:

2022

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Article Link

Year:

2022

Collaborators13

Lianne Reus

Assistant Professor

Amsterdam UMC Locatie VUmc

NETHERLANDS

Harro Seelaar

NETHERLANDS

Sanne Abeln

University of Amsterdam

NETHERLANDS

Marta del Campo Milan

Amsterdam University Medical Centers

NETHERLANDS

Pieter Jelle Visser

Karolinska Institutet

SWEDEN

ka wan li

University of Amsterdam

NETHERLANDS

Dea Gogishvili

University of Amsterdam

NETHERLANDS

Katharina Waury

Vrije Universiteit Amsterdam

NETHERLANDS

David Irwin

Assistant Professor

University of Pennsylvania

UNITED STATES

Charlotte Teunissen

University of Amsterdam

NETHERLANDS

Alberto Rábano

Head of Neuropathology

SPAIN

Giovanni Bellomo

University of Perugia

ITALY

Elly M. Hol

NETHERLANDS

How do I reach out?

Meet Kite AI